Attention deficit disorder in adults. Management in primary care.
OBJECTIVE
To review the ways attention deficit disorder (ADD) presents in adults in primary care and to suggest treatment approaches.


METHODS
PsycINFO, PubMed, and Academic Search Elite databases were searched. Level I evidence supports the effectiveness of stimulants for treating ADD in adults, and mixed evidence (levels I and II) supports the effectiveness of antidepressants.


RESULTS
Attention deficit disorder is a prevalent but often unrecognized disorder in adults. The diagnosis, which must include onset of symptoms before age 7, is often missed. This could be because family physicians are not always familiar with the presentation in adults, because it frequently presents with comorbid problems, or because specific questions are not asked to elicit the diagnosis. Diagnosis is based on clinical assessment often assisted by self-rating scales. Management includes support and education, helping patients develop additional structure in their lives and make necessary behavioural changes, enhancing self-esteem, supporting and educating families, and prescribing medication. Medication choices include stimulants and antidepressants; medication can benefit up to 60% of people with ADD.


CONCLUSIONS
It is crucial for primary care physicians to identify ADD in adults and to initiate treatment or referral. Several simple interventions can be employed.
Kates
Nick
N
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ont.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000628:therapy*; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005194:Family Practice; D006801:Humans; D008487:Medical History Taking
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants
J Clin Psychiatry. 1998;59 Suppl 7:69-75
9680055
Compr Psychiatry. 1997 May-Jun;38(3):133-40
9154368
J Atten Disord. 2002 Sep;6(2):69-75
12142863
J Clin Psychiatry. 1998;59 Suppl 7:76-9
9680056
J Dev Behav Pediatr. 1998 Apr;19(2):77-83
9584935
JAMA. 2003 Sep 24;290(12):1565-7
14506100
CMAJ. 2003 Mar 18;168(6):715-22
12642429
Biol Psychiatry. 2003 Jan 15;53(2):112-20
12547466
Psychiatr Clin North Am. 2004 Jun;27(2):187-201
15063992
Am J Psychiatry. 2001 Feb;158(2):282-8
11156812
J Clin Psychiatry. 1998;59 Suppl 7:4-16
9680048
Med J Aust. 1999 Oct 18;171(8):421-5
10590746
Psychiatr Clin North Am. 1998 Dec;21(4):761-74, v
9890120
J Clin Psychopharmacol. 2004 Feb;24(1):24-9
14709943
Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr;26(3):585-9
11999912
J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S
11833633
Ann Clin Psychiatry. 2001 Sep;13(3):129-34
11791949
Am J Psychiatry. 1993 Jun;150(6):885-90
8494063
J Atten Disord. 2002 Mar;5(4):189-202
11967475
Am J Psychiatry. 1996 Sep;153(9):1147-53
8780417
Ann N Y Acad Sci. 2001 Jun;931:1-16
11462736
Ann N Y Acad Sci. 2001 Jun;931:302-9
11462749
Pediatrics. 2000 May;105(5):1158-70
10836893
J Clin Psychiatry. 2002;63 Suppl 12:3-9
12562055
Am J Psychiatry. 2002 Nov;159(11):1882-8
12411223
Am J Psychiatry. 1993 Dec;150(12):1792-8
8238632